EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire

John R Ingram, Valerie Ciaravino, Robert Rolleri, Ingrid Pansar, Carla Dias-Barbosa, Joslyn S Kirby

Dermatology · 2024

DOI: 10.1159/000534463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology, 2024. Verfasst von John R Ingram und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Academic Wound Healing, Division of Infection and Immunity, Cardiff University, Cardiff, UK. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hidradenitis suppurativa (HS), a chronic skin condition that causes pain and physical dysfunction, can impact significantly on quality of life. Disease-specific tools have been designed to assess the impact of HS on patients, including the HS Symptom Daily Diary (HSSDD), the HS Symptom Questionnaire (HSSQ), and the HS Quality of Life (HiSQOL©) questionnaire, which have been developed into electronic instruments (eHSSDD, eHSSQ, and eHiSQOL©).

Objectives

The objective of this study was to establish the content validity of the electronic version of the HSSDD and HSSQ, and the acceptability and usability of the HSSDD, HSSQ, and HiSQOL©, using concept elicitation and cognitive debriefing interviews.

Methods

This was a non-interventional qualitative video interview study involving participants aged ≥18 years with moderate to severe HS recruited from a single clinical site in the USA. Interviews gathered feedback on participants’ symptom experience, followed by training and completion of the eHSSDD, eHSSQ, and eHiSQOL© questionnaires on electronic handheld devices. Participants were then interviewed on the content of the eHSSDD and eHSSQ and the acceptability and usability of all three instruments. Interviews were transcribed and qualitatively analysed.

Results

Twenty participants with moderate to severe HS (median age: 41.5 [range: 20.0–64.0]; n = 16/20 female) were included. All participants found the eHSSDD, eHSSQ, and eHiSQOL© instructions clear and described the instruments as “easy”, “simple” and “self-explanatory”. Overall understanding of individual items within the eHSSDD and eHSSQ was high; however, 6/20 participants had difficulty in understanding the average skin pain item in the eHSSDD. All participants were able to accurately recall their symptoms within the recall periods of the eHSSDD and eHSSQ, although 4/20 participants found the 24-h recall period of the eHSSDD limiting. Completion time was quick across all instruments, and usability was high, with the majority of participants reporting no difficulty in completing questionnaires on electronic devices.

Conclusion

The concepts covered in the eHSSDD and eHSSQ are relevant and important to patients, supporting their content validity. The findings also provide evidence of acceptability and usability of the eHSSDD, eHSSQ, and eHiSQOL©. A limitation was that all participants were recruited from a single site, which may have introduced selection bias and thus limited the generalisability of results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaHumansFemaleAdolescentAdultQuality of LifeSurveys and QuestionnairesPainPatient Reported Outcome Measures

Stichwörter der Autor:innen

Cognitive interviewsConcept elicitationHidradenitis suppurativaPatient-reported outcomesUsability testing

Autor:innen und Institutionen

  • Department of Dermatology and Academic Wound Healing, Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • UCB Pharma, Colombes, France.
  • UCB Pharma, Morrisville, North Carolina, USA.
  • UCB Pharma, Brussels, Belgium.
  • Evidera, Bethesda, Maryland, USA.
  • Department of Dermatology, Penn State University, Hershey, Pennsylvania, USA.

Zitieren

APA

Ingram, J. R., Ciaravino, V., Rolleri, R., Pansar, I., Dias-Barbosa, C., & Kirby, J. S. (2024). Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire. Dermatology. https://doi.org/10.1159/000534463

Vancouver

Ingram JR, Ciaravino V, Rolleri R, Pansar I, Dias-Barbosa C, Kirby JS. Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire. Dermatology. 2024. doi:10.1159/000534463

BibTeX
@article{Ingram2024,
  author = {Ingram, John R and Ciaravino, Valerie and Rolleri, Robert and Pansar, Ingrid and Dias-Barbosa, Carla and Kirby, Joslyn S},
  title = {Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire},
  journal = {Dermatology},
  year = {2024},
  doi = {10.1159/000534463}
}
Kostenlos starten →